Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 762 to 811 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.091\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04901\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u4/u6-associated rna splicing factor. [source:refseq;acc:nm\_004698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.082\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.707\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.045\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.343\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.226\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04875\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho interacting protein 3. [source:refseq;acc:nm\_015134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.803\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.224\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04874\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 4 (heat shock 40 kda protein 1 homolog) (heat shock protein 40 homolog) (hsp40 homolog). [source:swissprot;acc:q9udy4]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
210.946\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.225\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 5 (heat shock protein hsp40-3) (heat shock protein cognate 40) (hsc40) (hsp40-2). [source:swissprot;acc:o75953]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 1 (heat shock 40 kda protein 1) (heat shock protein 40) (hsp40) (dnaj protein homolog 1) (hdj-1). [source:swissprot;acc:p25685]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic peptide chain release factor subunit 1 (erf1) (eukaryotic release factor 1) (tb3-1) (c11 protein). [source:swissprot;acc:p46055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multiple coagulation factor deficiency 2; neural stem cell derived neuronal survival protein; multiple coagulation factor deficiency protein 2. [source:refseq;acc:nm\_139279]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.996\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04854\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 2 (hd2). [source:swissprot;acc:q92769]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.003\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.541\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.996\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 1 (hd1). [source:swissprot;acc:q13547]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.989\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 6 (traf4-associated factor 2). [source:swissprot;acc:q9unh7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.191\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxycytidylate deaminase (ec 3.5.4.12) (dcmp deaminase). [source:swissprot;acc:p32321]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
230.516\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.641\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04826\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.4 kda polypeptide (ec 2.7.7.6) (rpb6) (rpb14.4) (rpabc2). [source:swissprot;acc:p41584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.762\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.933\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04799\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein p0-like protein; 60s acidic ribosomal protein po; ribosomal protein, large, p0-like. [source:refseq;acc:nm\_016183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
245.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
257.636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin. [source:swissprot;acc:q15631]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.385\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
235.131\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04789\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyglutamine binding protein 1; nuclear protein containing ww domain 38 kd. [source:refseq;acc:nm\_005710]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuroepithelial cell transforming gene 1; guanine nucleotide regulatory protein (oncogene); rho guanine nucleotide exchange factor (gef) 8. [source:refseq;acc:nm\_005863]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
244.447\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.508\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04685\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 3; rhogef protein; 59.8 kda protein; exchange factor found in platelets and leukemic and neuronal tissues, xpln. [source:refseq;acc:nm\_019555]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
down-regulated in metastasis. [source:refseq;acc:nm\_014503]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
138.705\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.538\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04653\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein sa (p40) (34/67 kda laminin receptor) (colon carcinoma laminin-binding protein) (nem/1chd4) (multidrug resistance- associated protein mgr1-ag). [source:swissprot;acc:p08865]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.244\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
234.511\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s21. [source:swissprot;acc:p35265]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 3 (cap3) (cap-3) (protease inhibitor 9) (serpin b9). [source:swissprot;acc:p50453]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leukocyte elastase inhibitor (lei) (monocyte/neutrophil elastase inhibitor) (m/nei) (ei). [source:swissprot;acc:p30740]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.965\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.404\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04501\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.894\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04445\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to nuclear protein e3-3 orf1. [source:sptrembl;acc:q9bu61]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
a kindred of iglon. [source:refseq;acc:nm\_173808]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ankyrin-repeat family a protein 2 (rfxank-like 2). [source:swissprot;acc:q9h9e1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 1 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 1). [source:swissprot;acc:p50897]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-soluble nsf attachment protein (snap-beta) (n-ethylmaleimide- sensitive factor attachment protein, beta). [source:swissprot;acc:q9h115]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 16 (syn16). [source:swissprot;acc:o14662]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/